Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi-Aventis Hits Trail Blazing 42 Percent Growth In April As Indian Drug Market Sprints By 24 Percent

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - June is a keenly awaited month for large and small pharmaceutical companies operating in India as it signals the onset of a long spell of the monsoon season bringing in the rains and effectively meaning peak sales for drug companies riding on the surge in demand in a broad range of anti-infective and common cold and cough drugs
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

SC075073

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel